We are Cmed, a global CRO where technology meets expertise in oncology, cell & gene therapy, and rare disease. For over 20 years, our experience has enabled us to refine and evolve to incorporate the technology, processes, and insights necessary to ensure your clinical trial needs are future proof. Our approach gives us the flexibility to meet the ever changing needs of biotech and biopharma companies worldwide.
We specialise in oncology trials and are focused on serving the biopharma/biotech market. We strive to be a consultative and proactive CRO partner. No matter how complex, our customised solutions are designed around the individual needs of each of our biopharma clients.
Rare disease research can be challenging and often there are no precedents to rely on. Cmed is the right CRO partner to help you navigate those hidden challenges and maximise outcomes because of our depth of experience and operational expertise.
We understand the complexities that come with Cell & Gene therapy trials for oncology, rare diseases, and other therapeutic areas. We are a CRO partner of choice because we know how to operationalise and deliver quality results on time.